StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the software maker’s stock.
Veradigm Price Performance
Shares of MDRX opened at $9.50 on Thursday. Veradigm has a 1-year low of $5.01 and a 1-year high of $11.80. The firm has a 50 day simple moving average of $9.98 and a 200-day simple moving average of $9.73.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- EV Stocks and How to Profit from Them
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- The Risks of Owning Bonds
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
